Sonrotoclax
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines .
Product Specifications
CAS Number
2383086-06-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
890.1
Molecular Formula
C49H59N7O7S
Notes
Research use only, not for human use.
Receptor
BCL
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CABT-ZB496 50 μl
Mouse Anti-Human IL-7 monoclonal antibody, clone NN17
Sign In for Pricing
View Details M9848-01A-Biotin 200 µL
Myosin 1C, ID (Myosin I beta, MMI-beta, MMIb, Myosin-Ic, MYO1C) (Biotin) discontinued
Sign In for Pricing
View Details